CLINICAL_TRIALS
trial_result
· 2019-09-19
Clinical Trial Update: Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide [Phase 2]
Summary
Phase 2 trial evaluating cytokine level changes in patients with persistent diabetic macular edema treated with triamcinolone acetonide.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Unity Health Toronto | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED